Explore the future of diabetes medication and how digital tools revolutionize patient care and treatment management.
Diabetes Medications: Current Treatments and the Future of Diabetes Care
Diabetes medications help control blood glucose and reduce the risk of diabetes-related complications. However, not every medicine works in the same way. For example, some medicines improve insulin sensitivity. Others increase insulin release, reduce glucose production, or help the kidneys remove glucose from the body. Insulin itself replaces a hormone that the body cannot make in enough amounts.
Today, diabetes care involves more than managing blood sugar. Doctors may also consider heart and kidney health, body weight, the risk of low blood sugar, side effects, cost, and each person’s treatment preferences. As a result, the best diabetes medication may differ from one person to another.This guide explains the main diabetes medications used today. It also distinguishes established treatments from newer therapies that researchers are still studying.
Key Takeaways
- Metformin remains an important treatment option for many people with type 2 diabetes.
- Insulin is essential for people with type 1 diabetes and is also used in some people with type 2 diabetes.
- GLP-1 receptor agonists can improve blood glucose and may support weight management.
- SGLT2 inhibitors can provide important cardiovascular and kidney benefits in selected patients.
- DPP-4 inhibitors are oral medicines that generally have a low risk of hypoglycemia when used alone.
- Future diabetes care may include improved insulin delivery, cell replacement, immune therapies and new combination treatments.
- Diabetes medications should always be selected according to the person’s health needs and treatment goals.
How Doctors Choose Diabetes Medications
No single diabetes medicine works best for everyone. Instead, doctors choose treatment based on each person’s needs. For adults with type 2 diabetes, current guidance also encourages patients and doctors to work together when choosing a medicine to lower blood sugar.
Doctors may consider:
- Blood glucose and A1C levels
- Type of diabetes
- Cardiovascular disease
- Heart failure
- Chronic kidney disease
- Body weight and weight goals
- Risk of hypoglycemia
- Side effects
- Cost and access
- Other medicines
- Patient preferences
For example, an SGLT2 inhibitor may help people with type 2 diabetes and heart failure. It may also help those with chronic kidney disease. Similarly, doctors may consider a GLP-1 receptor agonist when weight or heart health is a concern.
The 2026 American Diabetes Association Standards of Care support this approach. They also advise doctors to consider medicines that may protect the heart or kidneys. This may help some people, even when their blood sugar is at the target level.
Current Diabetes Medications
The following table, in turn, summarizes five important classes of diabetes medications.
| Drug class | Examples | How they work | Common role | Important safety points |
|---|---|---|---|---|
| Metformin | Metformin | Reduces glucose production by the liver and improves insulin sensitivity | Common option for type 2 diabetes | Gastrointestinal effects can occur. Long-term use may be associated with vitamin B12 deficiency. Kidney function matters. |
| Insulin | Human insulin and insulin analogs | Replaces or supplements insulin so glucose can enter cells | Essential for type 1 diabetes; also used when some people with type 2 diabetes need insulin | Can cause hypoglycemia and weight gain. Doses must be individualized. |
| GLP-1 receptor agonists | Semaglutide, liraglutide and others | Increase glucose-dependent insulin release, reduce glucagon and slow gastric emptying | Type 2 diabetes, especially when weight or cardiovascular factors are important | Gastrointestinal effects are common. Product-specific warnings and contraindications apply. |
| SGLT2 inhibitors | Empagliflozin, dapagliflozin and others | Increase glucose loss through urine | Type 2 diabetes, especially when cardiovascular or kidney benefits are important | Genital infections and dehydration can occur. Diabetic ketoacidosis is an uncommon but important risk. |
| DPP-4 inhibitors | Sitagliptin, linagliptin and others | Increase incretin activity and support glucose-dependent insulin release | Oral treatment option for type 2 diabetes | Generally low hypoglycemia risk when used alone. Drug-specific warnings still apply. |
This table is a simplified educational overview. Individual medicines within a class can have different approved uses, doses, contraindications and warnings.
Metformin Diabetes Medications
Metformin is a common medicine for diabetes. It lowers the amount of sugar made by the liver and helps the body use insulin better. Because of this, many people with type 2 diabetes medication take metformin.
However, metformin is not right for everyone. Doctors should check kidney function before and during treatment. Some people may have nausea, diarrhea, or other stomach problems. Taking metformin with food or using a different form of the medicine may help reduce these effects. Over time, metformin may lower vitamin B12 levels. For this reason, the 2026 ADA Standards of Care suggest checking vitamin B12 from time to time, especially in people who have anemia or nerve problems.
Insulin
Insulin is a hormone. It helps move sugar from the blood into the body’s cells. People with type 1 diabetes need insulin because their bodies make little or none. Without insulin, blood sugar can rise to dangerous levels.Insulin can also help people with type 2 diabetes. Doctors may prescribe it when blood sugar is very high. They may also use it when other medicines do not work well enough.
Modern insulin treatment includes:
- Basal insulin
- Mealtime insulin
- Premixed insulin
- Insulin pens
- Insulin pumps
- Automated insulin delivery systems
These options can make treatment easier to change. However, insulin can cause low blood sugar. So, talk with your health care team before changing your insulin dose.
GLP-1 receptor Agonists
GLP-1 receptor agonists are a newer type of diabetes medication. They work like a natural hormone called GLP-1. These medicines help the body release more insulin when blood sugar is high. They also lower another hormone called glucagon and slow digestion.As a result, many people have better blood sugar control. Some people also lose weight.
In addition, some GLP-1 medicines may help protect the heart in certain people. Because of this, doctors now use these medicines for more than just lowering blood sugar.
These medicines can cause nausea, vomiting, diarrhea, or constipation. Side effects may be more common when you first start treatment or take a higher dose.Use only approved medicines from trusted sources. The FDA has warned about the risks of unapproved or incorrectly mixed GLP-1 medicines.
SGLT2 inhibitors
SGLT2 inhibitors work mainly through the kidneys. Normally, the kidneys return sugar to the blood. However, SGLT2 inhibitors reduce this process. As a result, more sugar leaves the body in the urine.
SGLT2 inhibitors do more than lower blood sugar. Some may also protect the heart and kidneys. Doctors may consider these medicines for people with type 2 diabetes and heart failure. They may also help people with type 2 diabetes and chronic kidney disease.
Possible problems include:
- Genital fungal infections
- Dehydration
- Low blood pressure in susceptible people
- Rare diabetic ketoacidosis
Because of this, ask your health care professional how to manage your medicine during serious illness, long periods without food, or surgery.
DPP-4 inhibitors
DPP-4 inhibitors are oral diabetes medications. They increase the activity of hormones called incretins, which help the body release insulin when blood sugar is high. As a result, these medicines usually have a low risk of low blood sugar when used alone.
They may suit people who prefer an oral diabetes medication with a low risk of low blood sugar. However, the 2026 ADA Standards of Care do not recommend using a DPP-4 inhibitor with a GLP-1 receptor agonist or a dual GIP/GLP-1 medicine. Using these medicines together does not lead to a meaningful extra drop in blood sugar.
Current Medicines vs. Future Diabetes Therapies
It is important to know the difference between approved diabetes medicines and new treatments still being tested. A new treatment may look helpful at first. However, doctors may need more studies before they use it. So, choose treatments that have been tested and approved for regular care.
Current Treatments Diabetes Medications The current treatment landscape includes:
- Metformin
- Insulin
- GLP-1 receptor agonists
- SGLT2 inhibitors
- DPP-4 inhibitors
- Other glucose-lowering medicines
- Automated insulin delivery systems
These treatments are already part of clinical diabetes care, although their use depends on the individual patient.
Future and Emerging Therapies
Improved Automated Insulin Delivery
Insulin pumps and glucose monitors now work together more closely. Some systems use glucose readings to adjust insulin doses on their own. This can make daily diabetes care easier and reduce the need for many dose changes.
However, people still need training and help from their health care team. Some people may also use these devices with diabetes medicine.
Stem-Cell-Derived Beta Cells
Insulin pumps and glucose monitors are working together more closely. Some systems use glucose readings to adjust insulin doses on their own. This may make daily diabetes care easier and reduce the need for many dose changes.
However, people still need training and help from their health care team. Some may also use these devices along with diabetes medicine.
Cell Replacement and Islet Therapies
Cell replacement aims to help the body make insulin again. It does this by adding healthy cells that produce insulin.
Doctors already use some cell and islet treatments in special cases. However, researchers are testing new ways to improve them. They want to make these treatments safer, work better, and help more people. In the future, these treatments may change how doctors use diabetes medicine.
Immune Therapies
Type 1 diabetes happens when the immune system attacks insulin-making cells in the pancreas. These cells are called beta cells. Because of this, researchers are studying ways to stop or slow the attack.
Some treatments can delay type 1 diabetes in people at high risk. However, doctors need more research before using them for more people. In the future, these treatments may change how doctors use diabetes medicine.
New Combination Medicines
Another area of research focuses on medicines that work in different ways. For example, some treatments use two or more hormones to help control blood sugar, hunger, and weight.
Some of these combined medicines are already approved. However, researchers are still working on others.
How to Use Diabetes Medications Safely
Diabetes medications can work very well, but you must use them correctly.
Follow these basic safety principles:
- Take medicines exactly as prescribed.
- Do not change your dose without professional guidance.
- Keep a current list of all medicines and supplements you use.
- Tell your healthcare professional about kidney or liver disease.
- Report significant side effects.
- Learn the warning signs of hypoglycemia if you use insulin or another medicine that can cause low blood glucose.
- Ask how to manage your medicine during illness, fasting, or surgery.
- Use prescription medicines from appropriate, regulated source Also, don’t assume a medicine is safe just because someone describes it as “natural,” “compounded,” or “new.”
Conclusion Diabetes Medications
Diabetes medications now offer more choices. Many also target specific health needs.
Metformin and insulin remain key parts of diabetes care. At the same time, GLP-1 receptor agonists and SGLT2 inhibitors do more than lower blood sugar. For some people, they may also support weight management and protect the heart and kidneys.
Frequently Asked Questions About Diabetes Medications
What are common diabetes medicines?
Common medicines include metformin, insulin, GLP-1 medicines, SGLT2 inhibitors, and DPP-4 inhibitors. Each works in a different way. Your doctor will choose a medicine based on your type of diabetes, health, and treatment goals.
Is one diabetes medicine best for everyone?
No. The best medicine depends on your health needs. Your doctor may consider your blood sugar, heart and kidney health, weight, other medicines, side effects, cost, and personal choices before making a treatment plan.
Can diabetes medicines protect the heart and kidneys?
Some medicines may help protect the heart or kidneys. For example, certain GLP-1 and SGLT2 medicines may offer these benefits. Your doctor can tell you if one of these medicines may be right for you.
What diabetes treatments are still being studied?
Researchers are studying new treatments, including combination medicines, cell replacement, and treatments that change the immune system. Some are already approved, while others need more research before doctors can use them widely.
Can I change my diabetes medicine on my own?
No. Always speak with your health care team before starting, stopping, or changing a diabetes medicine. Your dose may need to change during illness, fasting, or surgery. This can help prevent serious health problems.
References
- American Diabetes Association. Standards of Care in Diabetes—2026: Pharmacologic Approaches to Glycemic Treatment. Diabetes Care. 2026.
https://diabetesjournals.org/care/article/49/Supplement_1/S183/163934/9-Pharmacologic-Approaches-to-Glycemic-Treatment - Minari TP, et al. Nutritional Strategies for the Management of Type 2 Diabetes Mellitus. Nutrients. 2023;15(24):5096.
https://doi.org/10.3390/nu15245096 - U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. 2026.
https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
- Author
- Latest Posts
Ramya Dobbala is a pharmacist and science communicator dedicated to bridging the gap between complex pharmaceutical research and public understanding. A 2024 B.Pharmacy graduate, Ramya has a strong foundational background in formulation science, having spearheaded research into the evaluation and formulation of anti-acne creams. Her work focused on optimizing topical delivery systems to enhance treatment efficacy and skin health.
Transitioning from the laboratory to the forefront of scientific discourse, she now leverages her technical expertise to translate intricate healthcare concepts into accessible, engaging content. As an author and communicator, Ramya is passionate about empowering audiences with evidence-based insights, particularly in the realms of dermatology and pharmaceutical innovation.
